Management of Muscle Invasive Bladder Cancer with Bladder Preservation in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
Bladder cancer
Practice patterns
Radiation therapy
Russia
Survey
Journal
Journal of cancer education : the official journal of the American Association for Cancer Education
ISSN: 1543-0154
Titre abrégé: J Cancer Educ
Pays: England
ID NLM: 8610343
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
pubmed:
5
3
2020
medline:
28
10
2021
entrez:
5
3
2020
Statut:
ppublish
Résumé
Trimodality bladder preservation (BP) is an accepted alternative to radical cystectomy for patients with muscle invasive bladder cancer (MIBC). The global utilization of BP is variable, and practice patterns have not been previously studied in Russia. We sought to elucidate the contemporary BP practice patterns in Russia and determine the impact of the BP workshop on attitudes of Russian radiation oncologists (ROs) towards BP. The workshop was focused on patient workup, selection for BP, chemotherapy choices, radiation therapy (RT) contouring and planning, patient counseling. A total of 77 pre- and 32 matched post-workshop IRB-approved surveys, based on the workshop content, were analyzed using descriptive statistics to determine baseline clinical experience and patterns of care. The impact was judged by changes in participants' responses. A total of 56% of respondents had experience with delivering bladder-directed RT, and 60% of those treated both operable and inoperable MIBC patients. Only 10% felt uncomfortable offering an operable patient BP modality. Prior to the workshop, almost half of respondents estimated universal poor bladder (44%) and erectile functions (47%) after BP. The workshop resulted in dramatic change in participants' attitudes towards long-term urinary (Stuart-Maxwell test, p < 0.01) and sexual (exact McNemar test, p < 0.01) side effects. Prior to the workshop, only 47% of respondents routinely discussed smoking cessation (SC) with their patients, whereas after workshop, 88% agreed that SC discussion is mandatory (exact McNemar test, p = 0.04). BP for MIBC is commonly used in Russia. Our workshop resulted in dramatically improved understanding of long-term BP toxicities and inspired Russian ROs to incorporate SC counseling into routine clinical management.
Identifiants
pubmed: 32130672
doi: 10.1007/s13187-020-01728-y
pii: 10.1007/s13187-020-01728-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1005-1013Informations de copyright
© 2020. American Association for Cancer Education.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
doi: 10.3322/caac.21492
Caffo O, Fellin G, Graffer U, Luciani L (1996) Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire. Cancer. 78(5):1089–1097
doi: 10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.0.CO;2-Y
Donat SM, Shabsigh A, Savage C, Cronin AM, Bochner BH, Dalbagni G, Herr HW, Milowsky MI (2009) Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. Eur Urol 55(1):177–185
doi: 10.1016/j.eururo.2008.07.018
Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM et al (2017) Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462–475
doi: 10.1016/j.eururo.2016.06.020
Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 198(3):552–559
doi: 10.1016/j.juro.2017.04.086
Mitin T, Shipley WU, Efstathiou JA, Heney NM, Kaufman DS, Lee RJ, Zietman AL (2013) Trimodality therapy for bladder conservation in treatment of invasive bladder cancer. Curr Urol Rep 14(2):109–115
doi: 10.1007/s11934-012-0301-x
Solanki AA, Martin B, Korpics M, Small C, Harkenrider MM, Mitin T (2017) Bladder-preserving therapy patterns of care: a survey of US radiation oncologists. Int J Radiat Oncol Biol Phys 99(2):383–387
doi: 10.1016/j.ijrobp.2017.04.009
Quirt JS, Siemens DR, Zaza K, Mackillop WJ, Booth CM (2017) Patterns of referral to radiation oncology among patients with bladder cancer: a population-based study. Clin Oncol (R Coll Radiol) 29(3):171–179
doi: 10.1016/j.clon.2016.09.018
Fonteyne V, Rammant E, Ost P, Lievens Y, De Troyer B, Rottey S et al (2018) Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium. Clin Genitourin Cancer 16(6):e1159–e1e69
doi: 10.1016/j.clgc.2018.07.026
Wong MCS, Fung FDH, Leung C, Cheung WWL, Goggins WB, Ng CF (2018) The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep 8(1):1129
doi: 10.1038/s41598-018-19199-z
Pushkar DY, Govorov AV, Matveev VB (2008) The epidemiology of bladder cancer in Russia. Scand J Urol Nephrol Suppl 218:21–24
doi: 10.1080/03008880802365024
Mitin T (2017) Radical cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | opinion: no. Int Braz J Urol 43(2):188–191
doi: 10.1590/s1677-5538.ibju.2017.02.04
Huddart R, Birtle A, Lewis R, Bahl A, Falconer A, Maynard L, et al. Results of the SPARE feasibility study - selective bladder preservation against radical excision in muscle invasive T2/T3 transitional cell carcinoma of the bladder (CRUK/07/011). American Society for Radiation Oncology (ASTRO) 54th Annual Meeting; Boston, Massachusetts. International Journal of Radiation Oncology*Biology*Physics. 2012. S119
Arcangeli G, Strigari L, Arcangeli S (2015) Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: a systematic review of clinical trials. Crit Rev Oncol Hematol 95(3):387–396
doi: 10.1016/j.critrevonc.2015.04.006
Gladkov OA, Matveev VB, Mitin T, Nosov DA, Popov AM. Practical recommendations on medical management of bladder cancer. 2018. Available from: https://rosoncoweb.ru/standarts/RUSSCO/2018/2018-31.pdf
Ahamad A, Martinez A, Salenius S, Ross R, Efstathiou J, Fernandez E (2018) Routine bladder cancer treatment dictates divergence from trial-derived regimens: results of treatment at 44 radiotherapy centers. Urol Oncol 36(1):9 e19–9 e25
doi: 10.1016/j.urolonc.2017.09.010
Coppin CM, Gospodarowicz MK, James K, Tannock IF, Zee B, Carson J et al (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada clinical trials group. J Clin Oncol 14(11):2901–2907
doi: 10.1200/JCO.1996.14.11.2901
James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T, Hendron C, Lewis R, Waters R, Huddart RA, BC2001 Investigators (2012) Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 366(16):1477–1488
doi: 10.1056/NEJMoa1106106
Efstathiou JA, Bae K, Shipley WU, Kaufman DS, Hagan MP, Heney NM, Sandler HM (2009) Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. J Clin Oncol 27(25):4055–4061
doi: 10.1200/JCO.2008.19.5776
Zietman AL, Sacco D, Skowronski U, Gomery P, Kaufman DS, Clark JA, Talcott JA, Shipley WU (2003) Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 170(5):1772–1776
doi: 10.1097/01.ju.0000093721.23249.c3
Sauer R, Birkenhake S, Kuhn R, Wittekind C, Schrott KM, Martus P (1998) Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 40(1):121–127
doi: 10.1016/S0360-3016(97)00579-8
Crivelli JJ, Xylinas E, Kluth LA, Rieken M, Rink M, Shariat SF (2014) Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol 65(4):742–754
doi: 10.1016/j.eururo.2013.06.010
Giskes K, Kunst AE, Benach J, Borrell C, Costa G, Dahl E et al (2005) Trends in smoking behaviour between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health 59(5):395–401
doi: 10.1136/jech.2004.025684
Bassett JC, Gore JL, Chi AC, Kwan L, McCarthy W, Chamie K, Saigal CS (2012) Impact of a bladder cancer diagnosis on smoking behavior. J Clin Oncol 30(15):1871–1878
doi: 10.1200/JCO.2011.36.6518
McClelland S 3rd, Chernykh M, Dengina N, Gillespie EF, Likhacheva A, Usychkin S et al (2018) Bridging the gap in global advanced radiation oncology training: impact of a web-based open-access interactive three-dimensional contouring atlas on radiation oncologist practice in Russia. J Cancer Educ